ATE390922T1 - 2-aminobenzothiazole als cb1 rezeptor inverse agonisten - Google Patents
2-aminobenzothiazole als cb1 rezeptor inverse agonistenInfo
- Publication number
- ATE390922T1 ATE390922T1 AT04739840T AT04739840T ATE390922T1 AT E390922 T1 ATE390922 T1 AT E390922T1 AT 04739840 T AT04739840 T AT 04739840T AT 04739840 T AT04739840 T AT 04739840T AT E390922 T1 ATE390922 T1 AT E390922T1
- Authority
- AT
- Austria
- Prior art keywords
- sup
- aminobenzothiazole
- inverse agonist
- receptor inverse
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03013403 | 2003-06-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE390922T1 true ATE390922T1 (de) | 2008-04-15 |
Family
ID=33522251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04739840T ATE390922T1 (de) | 2003-06-20 | 2004-06-11 | 2-aminobenzothiazole als cb1 rezeptor inverse agonisten |
Country Status (14)
Country | Link |
---|---|
US (2) | US7297707B2 (de) |
EP (1) | EP1638556B1 (de) |
JP (1) | JP2007506654A (de) |
KR (1) | KR100809201B1 (de) |
CN (1) | CN100368407C (de) |
AT (1) | ATE390922T1 (de) |
AU (1) | AU2004251002B2 (de) |
BR (1) | BRPI0411699A (de) |
CA (1) | CA2528785A1 (de) |
DE (1) | DE602004012858T2 (de) |
ES (1) | ES2303077T3 (de) |
MX (1) | MXPA05013733A (de) |
RU (1) | RU2344132C2 (de) |
WO (1) | WO2005000301A1 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2294330T3 (es) | 2002-08-02 | 2008-04-01 | MERCK & CO., INC. | Derivados de furo(2,3-b)piridina sustituidos. |
EP1575901B1 (de) | 2002-12-19 | 2012-10-10 | Merck Sharp & Dohme Corp. | Substituierte amide |
KR100809201B1 (ko) * | 2003-06-20 | 2008-02-29 | 에프. 호프만-라 로슈 아게 | 카나바노이드 수용체 1 역작용제로서 2-아미노벤조티아졸 |
AR046132A1 (es) * | 2003-10-24 | 2005-11-23 | Solvay Pharm Gmbh | Composicin farmaceutica que contiene al menos un compuesto con actividad de receptor de cb1, o un profarmaco , tautomero o sal del mismo, como componente activo adecuado para el tratamiento y/o profilaxis de enfermedades relacionadas con el receptor cb1 en pacientes juveniles y/o para el tratamiento |
CN1867332A (zh) * | 2003-10-24 | 2006-11-22 | 索尔瓦药物有限公司 | 包含选择性cb1-拮抗剂和脂肪酶抑制剂的肥胖症的联合治疗 |
KR20090047458A (ko) | 2006-08-08 | 2009-05-12 | 사노피-아벤티스 | 아릴아미노아릴-알킬-치환된 이미다졸리딘-2,4-디온, 이의 제조방법, 이들 화합물을 포함하는 약제 및 이의 용도 |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
EP2242745A1 (de) * | 2008-02-07 | 2010-10-27 | Sanofi-Aventis | Neue phenyl-substituierte imidazolidine, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8470841B2 (en) | 2008-07-09 | 2013-06-25 | Sanofi | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
WO2010047982A1 (en) | 2008-10-22 | 2010-04-29 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
JP5557845B2 (ja) | 2008-10-31 | 2014-07-23 | メルク・シャープ・アンド・ドーム・コーポレーション | 糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体 |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
RU2012111354A (ru) | 2009-08-26 | 2013-10-10 | Санофи | Новые кристаллические гидраты фторгликозидов, содержащие их фармацевтические препараты и их использование |
AU2011218830B2 (en) | 2010-02-25 | 2014-07-24 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
JP5728099B2 (ja) | 2011-02-25 | 2015-06-03 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | 抗糖尿病剤として有用な新規環状アザベンゾイミダゾール誘導体 |
WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120054A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120058A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
US8809325B2 (en) | 2011-03-08 | 2014-08-19 | Sanofi | Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof |
EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120050A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120057A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
FR2974093B1 (fr) | 2011-04-15 | 2015-05-08 | Michelin Soc Tech | Procede de preparation d'un melange maitre d'elastomere et d'une charge inorganique renforcante |
US9527875B2 (en) | 2012-08-02 | 2016-12-27 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
RU2015140066A (ru) | 2013-02-22 | 2017-03-30 | Мерк Шарп И Доум Корп. | Противодиабетические бициклические соединения |
WO2014139388A1 (en) | 2013-03-14 | 2014-09-18 | Merck Sharp & Dohme Corp. | Novel indole derivatives useful as anti-diabetic agents |
WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
US11072602B2 (en) | 2016-12-06 | 2021-07-27 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3940418A (en) | 1972-04-07 | 1976-02-24 | G. D. Searle & Co. | Esters and amides of 4,5-dihydrobenz[g]indazole-3-carboxylic acids and related compounds |
US5376665A (en) * | 1992-05-21 | 1994-12-27 | Otsuka Pharmaceutical Factory, Inc. | Phosphonic diester derivatives |
FR2713225B1 (fr) | 1993-12-02 | 1996-03-01 | Sanofi Sa | N-pipéridino-3-pyrazolecarboxamide substitué. |
FR2692575B1 (fr) | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
FR2714057B1 (fr) | 1993-12-17 | 1996-03-08 | Sanofi Elf | Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant. |
US5596106A (en) * | 1994-07-15 | 1997-01-21 | Eli Lilly And Company | Cannabinoid receptor antagonists |
FR2741621B1 (fr) | 1995-11-23 | 1998-02-13 | Sanofi Sa | Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant |
FR2783246B1 (fr) | 1998-09-11 | 2000-11-17 | Aventis Pharma Sa | Derives d'azetidine, leur preparation et les medicaments les contenant |
IL141769A0 (en) * | 1998-09-11 | 2002-03-10 | Aventis Pharma Sa | Azetidine derivatives, preparation and medicines containing them |
FR2789079B3 (fr) | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
FR2800375B1 (fr) | 1999-11-03 | 2004-07-23 | Sanofi Synthelabo | Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant |
US6479479B2 (en) * | 2000-03-03 | 2002-11-12 | Aventis Pharma S.A. | Azetidine derivatives, their preparation and pharmaceutical compositions containing them |
FR2805818B1 (fr) | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant |
FR2805810B1 (fr) | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation |
US6355631B1 (en) * | 2000-03-03 | 2002-03-12 | Aventis Pharma S.A. | Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation |
US6566356B2 (en) * | 2000-03-03 | 2003-05-20 | Aventis Pharma S.A. | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
FR2805817B1 (fr) | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation |
JP2004500401A (ja) | 2000-03-23 | 2004-01-08 | ソルベイ・フアーマシユーチカルズ・ベー・ブイ | Cb1−拮抗活性を有する4,5−ジヒドロ−1h−ピラゾール誘導体 |
KR20020089493A (ko) * | 2000-04-28 | 2002-11-29 | 상꾜 가부시키가이샤 | PPARγ모듈레이터 |
FR2814678B1 (fr) | 2000-10-04 | 2002-12-20 | Aventis Pharma Sa | Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite |
ES2256340T3 (es) | 2000-12-06 | 2006-07-16 | F. Hoffmann-La Roche Ag | Activadores heteroaromaticos fusionados de la glucoquinasa. |
US6433188B1 (en) | 2000-12-06 | 2002-08-13 | Wendy Lea Corbett | Fused heteroaromatic glucokinase activators |
AU2002317377A1 (en) * | 2001-07-20 | 2003-03-03 | Cancer Research Technology Limited | Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer |
SE0102764D0 (sv) * | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
US6624163B2 (en) * | 2001-11-29 | 2003-09-23 | Hoffman-La Roche Inc. | Benzothiazole derivatives |
KR100809201B1 (ko) * | 2003-06-20 | 2008-02-29 | 에프. 호프만-라 로슈 아게 | 카나바노이드 수용체 1 역작용제로서 2-아미노벤조티아졸 |
-
2004
- 2004-06-11 KR KR1020057024471A patent/KR100809201B1/ko not_active IP Right Cessation
- 2004-06-11 BR BRPI0411699-2A patent/BRPI0411699A/pt not_active IP Right Cessation
- 2004-06-11 CA CA002528785A patent/CA2528785A1/en not_active Abandoned
- 2004-06-11 EP EP04739840A patent/EP1638556B1/de not_active Expired - Lifetime
- 2004-06-11 AU AU2004251002A patent/AU2004251002B2/en not_active Ceased
- 2004-06-11 JP JP2006515912A patent/JP2007506654A/ja active Pending
- 2004-06-11 ES ES04739840T patent/ES2303077T3/es not_active Expired - Lifetime
- 2004-06-11 CN CNB200480016731XA patent/CN100368407C/zh not_active Expired - Fee Related
- 2004-06-11 AT AT04739840T patent/ATE390922T1/de not_active IP Right Cessation
- 2004-06-11 DE DE602004012858T patent/DE602004012858T2/de not_active Expired - Lifetime
- 2004-06-11 WO PCT/EP2004/006354 patent/WO2005000301A1/en active IP Right Grant
- 2004-06-11 MX MXPA05013733A patent/MXPA05013733A/es active IP Right Grant
- 2004-06-11 RU RU2006101458/04A patent/RU2344132C2/ru not_active IP Right Cessation
- 2004-06-18 US US10/871,952 patent/US7297707B2/en not_active Expired - Fee Related
-
2006
- 2006-09-26 US US11/527,063 patent/US20070021478A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BRPI0411699A (pt) | 2006-08-29 |
ES2303077T3 (es) | 2008-08-01 |
CN1805745A (zh) | 2006-07-19 |
US20070021478A1 (en) | 2007-01-25 |
AU2004251002A1 (en) | 2005-01-06 |
US20040266845A1 (en) | 2004-12-30 |
KR20060012031A (ko) | 2006-02-06 |
AU2004251002B2 (en) | 2009-10-29 |
CN100368407C (zh) | 2008-02-13 |
RU2344132C2 (ru) | 2009-01-20 |
DE602004012858T2 (de) | 2009-05-14 |
WO2005000301A1 (en) | 2005-01-06 |
EP1638556A1 (de) | 2006-03-29 |
JP2007506654A (ja) | 2007-03-22 |
EP1638556B1 (de) | 2008-04-02 |
KR100809201B1 (ko) | 2008-02-29 |
RU2006101458A (ru) | 2007-07-27 |
MXPA05013733A (es) | 2006-03-08 |
US7297707B2 (en) | 2007-11-20 |
CA2528785A1 (en) | 2005-01-06 |
DE602004012858D1 (de) | 2008-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE390922T1 (de) | 2-aminobenzothiazole als cb1 rezeptor inverse agonisten | |
ATE384058T1 (de) | Thiazolderivate | |
TW200640867A (en) | Pyridine-3-carboxamide derivatives as CB1 inverse agonists | |
GB0504828D0 (en) | Therapeutic agents | |
ATE478856T1 (de) | Spirobenzodioxole und deren verwendung als cb1- antagonisten | |
MXPA05007115A (es) | Nuevos agonistas inversos del receptor cb 1. | |
ATE496620T1 (de) | 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren | |
WO2004048345A3 (en) | 2,5-diketopiperazines for the treatment of obesity | |
DE602005020655D1 (de) | Carboxamid-spirolactam-cgrp-rezeptor-antagonisten | |
ATE467632T1 (de) | Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors | |
EA200701357A1 (ru) | Композиции и способы применения модулятора рецептора 5ht | |
TW200740787A (en) | (6-Fluoro-benzo[1,3]dioxolyl)-morpholin-4-yl-methanones | |
NO20063275L (no) | Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom | |
UY27918A1 (es) | Derivados de benzodioxol | |
DE602006010738D1 (de) | Pyrroloä2,3-cüpyridinderivate | |
EA200500520A1 (ru) | Пуриновые соединения и их применение в качестве лигандов каннабиноидных рецепторов | |
DE602004009200D1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
MX2010002938A (es) | Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer. | |
MX2007004910A (es) | Nuevos derivados de indol o benzimidazol. | |
EP1856100A4 (de) | Cgrp-rezeptorantagonisten | |
CY1110130T1 (el) | Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α. | |
MX2007004661A (es) | Derivados de 1-(hetero)aril-3-amino-pirrolidina para usarse como antagonistas del receptor mglur3. | |
DE602007011434D1 (de) | 1h-indol-5-ylpiperazin-1-ylmethanonderivate | |
DK2201002T3 (da) | 5-HT7-receptorantagonister | |
BR0307903A (pt) | derivados de arilsulfona |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1638556 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |